Skip to main content
Premium Trial:

Request an Annual Quote

Incyte Genomics, GeneFormatics To Probe Human Protein Function

NEW YORK, April 23-GeneFormatics and Incyte Genomics will collaborate to probe the function of human proteins, the two companies said today.


Incyte will provide proprietary full-length human protein sequences to GeneFormatics, which will use its own structural proteomics technology to identify the function and structure of these proteins.


Incyte may use this data in its genomics patent filings. Financial details were not disclosed.


The collaboration will help validate GeneFormatics' technology and develop its licensing strategies, said CEO John Chiplin in a statement. The San Diego, Calif.-based company, which is privately held, uses a "functional family" approach to protein annotation that relies on structural and chemical proteomics.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.